Medication info
Rosu-Mjet Tablet 10/20 Milligrams (Ezetimibe, Rosuvastatin)

Rosu-Mjet Tablet 10/20 Milligrams (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium Micronized›20.8mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Pink rectangular film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202004139 · Approved 2020.05.29 · Insurance code 622804320

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used as an adjunct to diet to lower total cholesterol, LDL cholesterol, Apo B, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and to increase HDL cholesterol levels. Especially in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia, appropriate dietary measures and non-pharmacological strategies should be combined with lipid-lowering drugs. It is important to confirm secondary causes of dyslipidemia before starting medication and treat accordingly. Additionally, lipid tests including total cholesterol, LDL, HDL, and triglycerides should be regularly conducted to evaluate treatment progress. In the case of an acute coronary event, lipid levels should be checked promptly, and LDL-lowering treatment should begin upon discharge based on this assessment. This medication is effectively used for treating dyslipidemia and improving vascular health.

How to take

Adult dose

This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may rarely cause rhabdomyolysis, which can result in severe muscle damage, so patients with acute serious myopathy symptoms or those at risk for renal failure should temporarily stop or discontinue this medication. This medication should not be administered to patients with allergies to the active ingredient or excipients, active liver disease, unexplained liver enzyme abnormalities, muscle disorders, severe renal failure, pregnant women, or breastfeeding women. Special caution is required when administering to patients at high risk of myopathy or rhabdomyolysis, such as those with renal dysfunction, hypothyroidism, a history of muscle disorders, or a history of muscle toxicity with other statins or fibrates. Patients experiencing symptoms such as muscle pain, cramps, weakness, fatigue, fever, etc. while taking this medication should inform their physician immediately, and if necessary, blood tests should be performed to assess muscle damage. As liver function abnormalities may occur, liver function tests should be conducted before starting this medication, and symptoms of liver damage or changes in liver enzyme levels should be monitored regularly during treatment. Patients who consume large amounts of alcohol or have a history of liver disease should be cautious as this may increase the risk of liver damage while taking this medication. This medication should not be used during pregnancy or breastfeeding as it may harm the fetus or infant, and women of childbearing potential should use appropriate contraception. Safety in children and adolescents has not been established, so use is not recommended. Elderly patients (65 years and older) are at increased risk of myopathy and should be cautious during use, but dose adjustments are generally not necessary. This medication may interact with other drugs, particularly those including cyclosporine, fibrate drugs, anticoagulants, certain antibiotics, or antifungal agents, so consult a physician or pharmacist if you are taking these medications. In case of overdose, as there is no specific antidote, appropriate treatment and supportive therapy based on symptoms are necessary, and tests related to liver function and muscle damage should be performed. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

nasopharyngitis, arthralgia, headache, ALT elevation, AST elevation, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, unusual sensation, drug intolerance, colonic polyp, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, positional vertigo, migraine, diabetes, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased blood alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory impairment, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, myopathy, rhabdomyolysis, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, weakness, tremor, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastric region, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, anemia, splenomegaly, conjunctival hyperemia, renal failure, liver function abnormalities, elevated serum creatinine, increased blood pressure, elevated blood urea, increased CPK, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be stored at room temperature between 1°C and 30°C, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

Pink rectangular film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.